Total income decreased to Rs 6,645.81 crore for the quarter ended December 2017 from Rs 7,104.21 crore in the same quarter a year ago, IDBI Bank said in a statement.
Bank's gross non-performing assets (NPA) shot up to 24.72 per cent of gross advances during the quarter, against 15.16 per cent in the year-ago period.
Net NPAs too rose to 16.02 per cent of net advances, from 9.61 per cent in December 2016.
As a result, the bank's provision for bad loan increased to Rs 3,649.82 crore as compared to Rs 3,135.53 crore.
During the quarter, NPA write-off surged more than 5 folds to Rs 4,213.51 crore, as compared to Rs 778.32 crore in the corresponding quarter previous fiscal.
As part of the capital infusion, the government infused Rs 2,729 crore on December 29, 2017, by way of preferential allotment of equity shares and the same is shown as 'Equity Share Application Money' as on December 31, 2017, it said.
During the quarter, in line with the bank's strategy, it divested investment in Small Industries Development Bank of India, which has resulted in capital gain of Rs 616.20 crore.
On January 24, the government announced to infuse capital of Rs 10,610 crore into IDBI Bank.
Of which Rs 2,729 core has been received by the bank in December 2017 and the same has been considered in capital computation as on December 31, 2017.
IDBI Bank joined TReDS (Trade Receivables Discounting Scheme) platform with Receivables Exchange of India Limited (RXIL), a joint venture of NSE and SIDBI.
TReDS is a scheme for setting up and operating an institutional mechanism to facilitate the financing of trade receivable of MSMEs, it said, adding, the main objective is to ensure timely realisation of trade receivables and price discovery for MSMEs.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)